| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 | 1.36e-17 | 431 | 69 | 20 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 | 1.00e-11 | 884 | 69 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 ROR2 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 CHRNA4 | 4.35e-10 | 1353 | 69 | 22 | GO:0004888 |
| GeneOntologyMolecularFunction | N-succinyltransferase activity | 1.18e-05 | 2 | 69 | 2 | GO:0016749 | |
| GeneOntologyMolecularFunction | 5-aminolevulinate synthase activity | 1.18e-05 | 2 | 69 | 2 | GO:0003870 | |
| GeneOntologyMolecularFunction | succinyltransferase activity | 3.52e-05 | 3 | 69 | 2 | GO:0016748 | |
| GeneOntologyMolecularFunction | odorant binding | 9.80e-04 | 127 | 69 | 4 | GO:0005549 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 | 7.68e-18 | 432 | 69 | 20 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 | 3.20e-17 | 465 | 69 | 20 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 | 7.23e-17 | 485 | 69 | 20 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR11L1 EYS OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 | 1.54e-16 | 582 | 69 | 21 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 | 3.20e-16 | 524 | 69 | 20 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 | 7.27e-16 | 547 | 69 | 20 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR11L1 EYS OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 | 1.11e-14 | 722 | 69 | 21 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | OR11L1 EYS OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 CHRNA4 | 2.56e-12 | 1072 | 69 | 22 | GO:0007600 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR11L1 RNF113B OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 | 2.73e-09 | 1395 | 69 | 21 | GO:0007186 |
| Domain | Olfact_rcpt | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR1S1 OR13C2 OR1E1 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR1J4 | 1.23e-14 | 393 | 64 | 17 | IPR000725 |
| Domain | GPCR_Rhodpsn_7TM | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR1S1 OR13C2 OR1E1 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR1J4 | 6.31e-11 | 670 | 64 | 17 | IPR017452 |
| Domain | 7tm_1 | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR1S1 OR13C2 OR1E1 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR1J4 | 7.42e-11 | 677 | 64 | 17 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR1S1 OR13C2 OR1E1 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR1J4 | 8.90e-11 | 685 | 64 | 17 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR1S1 OR13C2 OR1E1 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR1J4 | 1.02e-10 | 691 | 64 | 17 | PS50262 |
| Domain | GPCR_Rhodpsn | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR1S1 OR13C2 OR1E1 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR1J4 | 1.04e-10 | 692 | 64 | 17 | IPR000276 |
| Domain | Preseq_ALAS | 1.16e-05 | 2 | 64 | 2 | PF09029 | |
| Domain | 4pyrrol_synth_NH2levulA_synth | 1.16e-05 | 2 | 64 | 2 | IPR010961 | |
| Domain | 5aminolev_synth_preseq | 1.16e-05 | 2 | 64 | 2 | IPR015118 | |
| Domain | AA_TRANSFER_CLASS_2 | 1.72e-04 | 6 | 64 | 2 | PS00599 | |
| Domain | Aminotrans_II_pyridoxalP_BS | 1.72e-04 | 6 | 64 | 2 | IPR001917 | |
| Domain | - | 3.46e-04 | 40 | 64 | 3 | 4.10.1000.10 | |
| Domain | ZnF_C3H1 | 5.95e-04 | 48 | 64 | 3 | SM00356 | |
| Domain | zf-CCCH | 6.32e-04 | 49 | 64 | 3 | PF00642 | |
| Domain | Znf_CCCH | 1.04e-03 | 58 | 64 | 3 | IPR000571 | |
| Domain | ZF_C3H1 | 1.04e-03 | 58 | 64 | 3 | PS50103 | |
| Domain | Aminotransferase_I/II | 1.52e-03 | 17 | 64 | 2 | IPR004839 | |
| Domain | Aminotran_1_2 | 1.52e-03 | 17 | 64 | 2 | PF00155 | |
| Domain | EGF_1 | 1.80e-03 | 255 | 64 | 5 | PS00022 | |
| Domain | EGF-like_CS | 2.00e-03 | 261 | 64 | 5 | IPR013032 | |
| Domain | EGF_2 | 2.13e-03 | 265 | 64 | 5 | PS01186 | |
| Domain | hEGF | 4.13e-03 | 28 | 64 | 2 | PF12661 | |
| Domain | EGF_Ca-bd_CS | 4.50e-03 | 97 | 64 | 3 | IPR018097 | |
| Domain | EGF_CA | 4.76e-03 | 99 | 64 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.90e-03 | 100 | 64 | 3 | PS00010 | |
| Domain | Serpin_CS | 5.37e-03 | 32 | 64 | 2 | IPR023795 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.76e-03 | 106 | 64 | 3 | IPR000152 | |
| Domain | - | 6.39e-03 | 35 | 64 | 2 | 3.90.1150.10 | |
| Domain | Serpin_dom | 6.76e-03 | 36 | 64 | 2 | IPR023796 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 6.76e-03 | 36 | 64 | 2 | IPR015422 | |
| Domain | SERPIN | 7.13e-03 | 37 | 64 | 2 | SM00093 | |
| Domain | SERPIN | 7.13e-03 | 37 | 64 | 2 | PS00284 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR11L1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR1J4 | 9.21e-16 | 417 | 56 | 19 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR11L1 PLB1 OR2T6 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR1J4 | 1.55e-13 | 636 | 56 | 20 | M41834 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR11L1 OR2T6 OR2T27 OR6N2 OR5B12 OR13C5 OR1Q1 OR1S1 OR13C2 OR1E1 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR1J4 | 1.27e-12 | 389 | 56 | 16 | M14091 |
| Pathway | WP_HEME_BIOSYNTHESIS | 5.48e-04 | 9 | 56 | 2 | M39470 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEME_BIOSYNTHESIS | 5.48e-04 | 9 | 56 | 2 | M47606 | |
| Pathway | WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS | 5.48e-04 | 9 | 56 | 2 | M45555 | |
| Pathway | WP_HEME_BIOSYNTHESIS | 5.48e-04 | 9 | 56 | 2 | MM15895 | |
| Pathway | WP_GPCRS_OTHER | 5.66e-04 | 96 | 56 | 4 | MM15939 | |
| Pubmed | OR11L1 OR2T27 OR6N2 OR2T35 OR5B12 OR13C5 OR1Q1 OR2T7 OR1S1 OR13C2 OR1E1 OR1E3 OR1G1 OR2T1 OR2T2 OR14C36 OR2T10 OR7A2P OR1J4 | 7.28e-19 | 541 | 69 | 19 | 14983052 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR11L1 OR2T6 OR6N2 OR2T35 OR5B12 OR1Q1 OR1S1 OR1E1 OR1E3 OR2T1 OR14C36 OR7A2P OR1J4 | 1.40e-13 | 340 | 69 | 13 | 11875048 |
| Pubmed | OR11L1 OR2T6 OR6N2 OR2T35 OR5B12 OR1Q1 OR1S1 OR1E1 OR1E3 OR2T1 OR14C36 OR7A2P OR1J4 | 1.40e-13 | 340 | 69 | 13 | 11802173 | |
| Pubmed | OR11L1 OR2T6 OR6N2 OR2T35 OR5B12 OR1Q1 OR1S1 OR1E1 OR1E3 OR2T1 OR14C36 OR7A2P OR1J4 | 1.57e-13 | 343 | 69 | 13 | 32295537 | |
| Pubmed | OR11L1 OR2T6 OR6N2 OR2T35 OR5B12 OR1Q1 OR1S1 OR1E1 OR1E3 OR2T1 OR14C36 OR7A2P OR1J4 | 1.75e-13 | 346 | 69 | 13 | 14611657 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 5.39e-10 | 219 | 69 | 9 | 12213199 | |
| Pubmed | Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species. | 1.09e-09 | 24 | 69 | 5 | 9119360 | |
| Pubmed | 1.22e-06 | 11 | 69 | 3 | 8004088 | ||
| Pubmed | Evolution of odorant receptors expressed in mammalian testes. | 2.11e-06 | 13 | 69 | 3 | 11014824 | |
| Pubmed | 2.17e-06 | 46 | 69 | 4 | 32126975 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15203214 | ||
| Pubmed | Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure. | 3.88e-06 | 2 | 69 | 2 | 23354406 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 22406480 | ||
| Pubmed | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. | 3.88e-06 | 2 | 69 | 2 | 27668655 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 2780318 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 2347585 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 22508697 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 2263504 | ||
| Pubmed | Characterization of novel squamous cell carcinoma antigen-related molecules in mice. | 3.88e-06 | 2 | 69 | 2 | 15504361 | |
| Pubmed | SCCA2-like serpins mediate genetic predisposition to skin tumors. | 3.88e-06 | 2 | 69 | 2 | 12702576 | |
| Pubmed | Serpinb3 is overexpressed in the liver in presence of iron overload. | 3.88e-06 | 2 | 69 | 2 | 28935635 | |
| Pubmed | Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins. | 3.88e-06 | 2 | 69 | 2 | 35022507 | |
| Pubmed | Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. | 3.88e-06 | 2 | 69 | 2 | 21403642 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25111616 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11267667 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 29491058 | ||
| Pubmed | Squamous cell carcinoma antigen production in nasal inverted papilloma. | 3.88e-06 | 2 | 69 | 2 | 23168150 | |
| Pubmed | The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. | 3.88e-06 | 2 | 69 | 2 | 11863458 | |
| Pubmed | The solution structure and heme binding of the presequence of murine 5-aminolevulinate synthase. | 3.88e-06 | 2 | 69 | 2 | 11566198 | |
| Pubmed | Serine 254 enhances an induced fit mechanism in murine 5-aminolevulinate synthase. | 3.88e-06 | 2 | 69 | 2 | 19917609 | |
| Pubmed | IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. | 3.88e-06 | 2 | 69 | 2 | 22808225 | |
| Pubmed | Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. | 3.88e-06 | 2 | 69 | 2 | 14970861 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 10653592 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 29112685 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 10956412 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 20428762 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 35874657 | ||
| Pubmed | Sequence, structure, and evolution of a complete human olfactory receptor gene cluster. | 4.11e-06 | 16 | 69 | 3 | 10673334 | |
| Pubmed | TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target. | 5.97e-06 | 18 | 69 | 3 | 34729304 | |
| Pubmed | Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells. | 1.16e-05 | 3 | 69 | 2 | 19070595 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 9828132 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 22451727 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 7724531 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 16234850 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 24898082 | ||
| Pubmed | A nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma. | 1.16e-05 | 3 | 69 | 2 | 21126757 | |
| Pubmed | Porcine odorant-binding protein selectively binds to a human olfactory receptor. | 1.16e-05 | 3 | 69 | 2 | 12379593 | |
| Pubmed | Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC). | 1.16e-05 | 3 | 69 | 2 | 24635038 | |
| Pubmed | Heparin enhances serpin inhibition of the cysteine protease cathepsin L. | 1.16e-05 | 3 | 69 | 2 | 19959474 | |
| Pubmed | Uteroglobin suppresses SCCA gene expression associated with allergic asthma. | 1.16e-05 | 3 | 69 | 2 | 15677460 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 23174213 | ||
| Pubmed | 1.29e-05 | 23 | 69 | 3 | 10706615 | ||
| Pubmed | A genomic analysis of rat proteases and protease inhibitors. | 1.29e-05 | 23 | 69 | 3 | 15060002 | |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 1.47e-05 | 74 | 69 | 4 | 15081110 | |
| Pubmed | 2.23e-05 | 591 | 69 | 8 | 15231748 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 16962228 | ||
| Pubmed | Odorant receptors govern the formation of a precise topographic map. | 2.32e-05 | 4 | 69 | 2 | 9546391 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 16549498 | ||
| Pubmed | Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1. | 2.32e-05 | 4 | 69 | 2 | 12949073 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 21576355 | ||
| Pubmed | Distribution of olfactory receptor genes in the human genome. | 2.36e-05 | 28 | 69 | 3 | 9500546 | |
| Pubmed | Allelic inactivation regulates olfactory receptor gene expression. | 3.86e-05 | 5 | 69 | 2 | 8087849 | |
| Pubmed | Fine genetic mapping of the Hyp mutation on mouse chromosome X. | 8.09e-05 | 7 | 69 | 2 | 8833143 | |
| Pubmed | Mouse-human orthology relationships in an olfactory receptor gene cluster. | 1.08e-04 | 8 | 69 | 2 | 11170746 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 16902085 | ||
| Pubmed | Sensitivity-dependent hierarchical receptor codes for odors. | 1.38e-04 | 9 | 69 | 2 | 12588732 | |
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 18814951 | ||
| Pubmed | 2.11e-04 | 272 | 69 | 5 | 31010829 | ||
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 15203215 | ||
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 26361056 | ||
| Pubmed | Erythropoietin contributes to implantation: ectopic hemoglobin synthesis in decidual cells of mice. | 2.11e-04 | 11 | 69 | 2 | 17300687 | |
| Pubmed | Organization and evolutionary relatedness of OR37 olfactory receptor genes in mouse and human. | 2.53e-04 | 12 | 69 | 2 | 12906860 | |
| Pubmed | HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? | 2.53e-04 | 12 | 69 | 2 | 18577246 | |
| Pubmed | 2.98e-04 | 13 | 69 | 2 | 11863365 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.27e-04 | 1105 | 69 | 9 | 35748872 | |
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 7528109 | ||
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 3.48e-04 | 14 | 69 | 2 | 27626314 | |
| Pubmed | Quantitative trait loci for steady-state platelet count in mice. | 4.01e-04 | 15 | 69 | 2 | 15520881 | |
| Pubmed | 4.01e-04 | 15 | 69 | 2 | 30704515 | ||
| Pubmed | Olfactory receptors and signalling elements in the Grueneberg ganglion. | 5.18e-04 | 17 | 69 | 2 | 16805845 | |
| Pubmed | 5.18e-04 | 17 | 69 | 2 | 37080995 | ||
| Pubmed | 7.95e-04 | 21 | 69 | 2 | 32939012 | ||
| Pubmed | 1.04e-03 | 24 | 69 | 2 | 24583261 | ||
| Pubmed | Expression of members of the putative olfactory receptor gene family in mammalian germ cells. | 1.13e-03 | 25 | 69 | 2 | 1370859 | |
| Pubmed | 1.32e-03 | 27 | 69 | 2 | 23740937 | ||
| Pubmed | Modulation of the combinatorial code of odorant receptor response patterns in odorant mixtures. | 1.32e-03 | 27 | 69 | 2 | 32061665 | |
| Pubmed | 1.42e-03 | 28 | 69 | 2 | 24322204 | ||
| Pubmed | 1.42e-03 | 28 | 69 | 2 | 35474067 | ||
| Pubmed | Molecular profiling of the vestibular lamina highlights a key role for Hedgehog signalling. | 1.74e-03 | 31 | 69 | 2 | 36971701 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.85e-03 | 262 | 69 | 4 | 36880596 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 1.93e-03 | 265 | 69 | 4 | 19240061 | |
| Cytoband | 1q44 | 9.37e-14 | 110 | 69 | 9 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 3.76e-13 | 128 | 69 | 9 | chr1q44 | |
| Cytoband | 18q21.3 | 1.21e-04 | 11 | 69 | 2 | 18q21.3 | |
| Cytoband | 17p13.3 | 3.25e-04 | 88 | 69 | 3 | 17p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 1.18e-03 | 137 | 69 | 3 | chr9q31 | |
| Cytoband | 9q31.1 | 1.76e-03 | 41 | 69 | 2 | 9q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.86e-03 | 346 | 69 | 4 | chr17p13 | |
| Cytoband | 14q23.1 | 2.30e-03 | 47 | 69 | 2 | 14q23.1 | |
| GeneFamily | Olfactory receptors, family 1 | 2.65e-09 | 40 | 57 | 6 | 147 | |
| GeneFamily | Olfactory receptors, family 2 | 6.31e-08 | 113 | 57 | 7 | 149 | |
| GeneFamily | Olfactory receptors, family 13 | 2.37e-03 | 23 | 57 | 2 | 162 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-2|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 5.83e-07 | 105 | 68 | 5 | 744be8b4255bef3a973db7e4306e52387852e502 | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 7.81e-06 | 178 | 68 | 5 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-06 | 178 | 68 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 189 | 68 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 189 | 68 | 5 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-05 | 191 | 68 | 5 | 9bb6a6b88f351217455765ba07a6acf11fda98f4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 192 | 68 | 5 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 192 | 68 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 192 | 68 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 192 | 68 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 193 | 68 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 194 | 68 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 195 | 68 | 5 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 195 | 68 | 5 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.31e-05 | 198 | 68 | 5 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.37e-05 | 200 | 68 | 5 | 5ed450e65edff713ad5feba4f6c46209bf471f6e | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 8.19e-05 | 55 | 68 | 3 | 7916216b3a24f9c6b966aa5392fc2bc43b3d2c4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 169 | 68 | 4 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-4_RORB_FOLH1B|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 172 | 68 | 4 | bbbd013ce554b2f93e463438fed20ec03fe87780 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-04 | 177 | 68 | 4 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-04 | 180 | 68 | 4 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-04 | 180 | 68 | 4 | cf7d8bf9eee2dfab2c8a6780e296b05ad42041bf | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.69e-04 | 181 | 68 | 4 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.72e-04 | 182 | 68 | 4 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 1.72e-04 | 182 | 68 | 4 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 1.76e-04 | 183 | 68 | 4 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 184 | 68 | 4 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-04 | 184 | 68 | 4 | 2f9c5887635185dc1c6ec4e959b6d8a28b0bd020 | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 1.91e-04 | 187 | 68 | 4 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-04 | 189 | 68 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-04 | 189 | 68 | 4 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-04 | 189 | 68 | 4 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-04 | 189 | 68 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 2.03e-04 | 190 | 68 | 4 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-04 | 190 | 68 | 4 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-04 | 190 | 68 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-04 | 191 | 68 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-04 | 191 | 68 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.07e-04 | 191 | 68 | 4 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.07e-04 | 191 | 68 | 4 | e94dfd2d8da81bfd16f2f1a4f3ac27b078eeb3ca | |
| ToppCell | background-B_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.07e-04 | 191 | 68 | 4 | a189fdc9c739bb0801e2f38af0932a1ea615cb34 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 192 | 68 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 192 | 68 | 4 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 192 | 68 | 4 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-04 | 192 | 68 | 4 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 192 | 68 | 4 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 192 | 68 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 192 | 68 | 4 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-04 | 192 | 68 | 4 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.11e-04 | 192 | 68 | 4 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 192 | 68 | 4 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 192 | 68 | 4 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 192 | 68 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 193 | 68 | 4 | 463274f394757fb2570ae885d58e1f9fa7e60c4a | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.16e-04 | 193 | 68 | 4 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 193 | 68 | 4 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.16e-04 | 193 | 68 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 193 | 68 | 4 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 194 | 68 | 4 | f4c9fc53ae31d58096906d9305b0b4082512a7e9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 194 | 68 | 4 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | COVID-19_Mild-CD4+_Tcm|COVID-19_Mild / Disease condition and Cell class | 2.20e-04 | 194 | 68 | 4 | 3be2b1c81e668ffdf593ff41d3ba211c26d77671 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 194 | 68 | 4 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-04 | 194 | 68 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 194 | 68 | 4 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 194 | 68 | 4 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 194 | 68 | 4 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-04 | 194 | 68 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 194 | 68 | 4 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 194 | 68 | 4 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-04 | 195 | 68 | 4 | cbe518b465b4ef32797ae6b608219207c08493df | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-SELL+_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 195 | 68 | 4 | 82561f6ed75ee33c2581fb25bd0997a9f0538cd8 | |
| ToppCell | distal-Epithelial-Differentiating_Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.24e-04 | 195 | 68 | 4 | 3fe6e49a9161fc9e5160251e6932cb5378175a54 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-04 | 195 | 68 | 4 | 136b06b0931a69b1241101f68c01c44c70365fd9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 195 | 68 | 4 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 195 | 68 | 4 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 195 | 68 | 4 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 195 | 68 | 4 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 195 | 68 | 4 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-04 | 196 | 68 | 4 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tnaive/CM_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.29e-04 | 196 | 68 | 4 | e7fd508cb9a8a5b3d1c0247dabf486c4434b5e94 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | distal-3-Epithelial-Differentiating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.29e-04 | 196 | 68 | 4 | 77635a0f86910c4019d3370e9c8ba41de176bcf3 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.29e-04 | 196 | 68 | 4 | faa39c567f24403e511b240c1d1a654ffadd8473 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-04 | 196 | 68 | 4 | de43dd0697e1daf4d50800957cf0b27b54a7a333 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 197 | 68 | 4 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.33e-04 | 197 | 68 | 4 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 197 | 68 | 4 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 197 | 68 | 4 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-04 | 197 | 68 | 4 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 197 | 68 | 4 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 197 | 68 | 4 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| Drug | AC1L9T6Z | 3.95e-06 | 11 | 67 | 3 | CID000455606 | |
| Drug | 2-amino-3-ketoadipate | 8.53e-06 | 2 | 67 | 2 | CID000440714 | |
| Drug | pregnanedione | 8.53e-06 | 2 | 67 | 2 | CID000135006 | |
| Drug | Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; PC3; HT_HG-U133A | 2.23e-05 | 193 | 67 | 6 | 1816_UP | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; PC3; HT_HG-U133A | 2.30e-05 | 194 | 67 | 6 | 4021_UP | |
| Disease | Dystonia, Limb | 5.42e-04 | 17 | 60 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 5.42e-04 | 17 | 60 | 2 | C0393610 | |
| Disease | Dystonia, Paroxysmal | 6.09e-04 | 18 | 60 | 2 | C0393588 | |
| Disease | Dystonia | 7.25e-04 | 86 | 60 | 3 | C0013421 | |
| Disease | eosinophil percentage of leukocytes | 7.75e-04 | 746 | 60 | 7 | EFO_0007991 | |
| Disease | Granulomatous Slack Skin | 9.15e-04 | 22 | 60 | 2 | C0376407 | |
| Disease | Adenocarcinoma of large intestine | 9.98e-04 | 96 | 60 | 3 | C1319315 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 1.00e-03 | 23 | 60 | 2 | C0079773 | |
| Disease | tobacco smoke exposure measurement | 1.09e-03 | 24 | 60 | 2 | EFO_0009115 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.49e-03 | 28 | 60 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | stimulant use measurement | 1.49e-03 | 28 | 60 | 2 | EFO_0600076 | |
| Disease | Lymphoma | 3.02e-03 | 40 | 60 | 2 | C0024299 | |
| Disease | Autoimmune Diseases | 3.32e-03 | 42 | 60 | 2 | C0004364 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 3.48e-03 | 43 | 60 | 2 | DOID:9261 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CSIDVTFFPFDQQNC | 161 | P43681 | |
| EFIFAPRLDNLHSCF | 266 | Q9ULA0 | |
| TFHRCRFCFQLLTFD | 351 | A4D0V7 | |
| HICFEGQCRNTSFFE | 636 | Q9H013 | |
| DLEEFCFRFCINHLT | 506 | O95199 | |
| QLSFCTDLEIPHFFC | 166 | Q8NGA2 | |
| HTFQNECFFCVEQRE | 66 | Q1W4C9 | |
| FCNHNTLPHFFCDLA | 181 | Q8NH92 | |
| FPFCNSREINHFFCE | 216 | O43869 | |
| SFPFCRSREINHFFC | 166 | Q6IF00 | |
| LTNRFFCNCEPEYHG | 946 | Q5T1H1 | |
| SAECNFCRRPLHFEV | 606 | P13196 | |
| ANTLFQCVCYHPEEF | 501 | Q8N1V2 | |
| FCRSNVIHQFFCDIP | 166 | Q8NHC7 | |
| LPFCASHQINHFFCE | 166 | Q8NHC8 | |
| QFPFCASREINHFFC | 156 | P0C7T2 | |
| QSFCDRFLNSPLFHA | 81 | A0A1B0GTH6 | |
| ACFPFAFCRDCQFLE | 76 | A8MQ11 | |
| CCFTLPRESAEAFHN | 341 | Q8IV20 | |
| NAARFINHSCEPNCF | 2646 | Q9UMN6 | |
| LDFCGRNQINHFFCD | 166 | Q8NGX0 | |
| FPFCASREINHFFCE | 166 | Q8NH04 | |
| LPFCRNNIINHFTCE | 166 | Q8NGS8 | |
| FPFCRSREINHFFCE | 166 | Q8NGX2 | |
| LPFCRNNIINHFTCE | 166 | Q8NGS9 | |
| FCRSNVVEHFFCDAP | 166 | Q96R08 | |
| SVAACNFCRRPVHFE | 551 | P22557 | |
| LSFCADNTIPHFFCD | 166 | Q8NGS1 | |
| LSFCANHEIPHFFCD | 166 | P47890 | |
| FPFCRSHEIQHFFCE | 166 | Q8NGZ9 | |
| DCGFSLNHPNQFFCE | 436 | P49643 | |
| LPFCAYNEIQHIFCD | 166 | Q8NGY6 | |
| ISFIFCCFRNNDHPE | 11 | Q9Y4D1 | |
| PANLDSESEHFFRCC | 1886 | Q13315 | |
| QACAQPFEAFEECLR | 56 | Q9BSY4 | |
| SQERVNCFCLVFPFR | 221 | Q9UN19 | |
| TDFVDVPCSHFCNNF | 136 | P09871 | |
| VHEVDIFRCFCPVFL | 266 | Q8IWF6 | |
| ARLFIFETFCRIHQC | 336 | P60228 | |
| FHCSQCRNSLVDKPF | 66 | Q14192 | |
| VFCAQLQCFHFPTLR | 231 | P98153 | |
| CHPCFQTYDADLREQ | 581 | Q13751 | |
| AALFEACCSDRIQPF | 616 | O75170 | |
| DCVHQLQRQFPCSFE | 481 | Q13615 | |
| LSFCAENVIPHFFCD | 166 | Q8WZA6 | |
| LCFCADNVIPHFFCD | 166 | P30953 | |
| LIFCADNRIPHFFCD | 166 | Q15612 | |
| ENFFILICPVCDRSH | 181 | Q8IWZ5 | |
| EIPFRCFICRQAFQN | 251 | Q8IZP6 | |
| DQCSQFAIPSFCHFV | 221 | Q01974 | |
| CDFCNDLVHYSPQNF | 516 | Q6P1J6 | |
| SQVFHECFFNPCHNS | 1191 | Q4LDE5 | |
| EEFHCNHPFLFFIRQ | 361 | P29508 | |
| FATVCQECTDFHFPR | 346 | Q9NQ89 | |
| PFICHVCNKAFRTNF | 936 | Q9ULJ3 | |
| TNLHCILDFFCEFSE | 346 | Q5VZE5 | |
| FRTCQFCPQFREIIH | 51 | P21580 | |
| KCSQHNRLREFFCPE | 156 | Q14258 | |
| NRLREFFCPEHSECI | 161 | Q14258 | |
| FCLHFNCNESFKLPF | 816 | Q8IZM8 | |
| IFQAQCSFPECHELF | 841 | Q8IZM8 | |
| NLSVDPCDNFFRFAC | 71 | P78562 | |
| EEFCCNHPFLFFIRQ | 361 | P48594 | |
| FRTEQCPLFSQHKCA | 31 | Q9H9P5 | |
| HQDRGETFQCQLCPF | 426 | Q17R98 | |
| HRCDQCPQTFNVEFN | 66 | Q9UL36 | |
| QVEHCRQRDFLPFVC | 11 | Q8TCF1 | |
| FECPNCHERFARNST | 356 | P52739 | |
| FIFCHDFQNKECSRP | 76 | Q96K80 | |
| ANCCQSITPDEFHFV | 586 | Q14669 | |
| TDCFHCHVFPFLQQE | 236 | Q13488 | |
| PFQCHLCDRAFSRSD | 331 | Q9Y5W3 | |
| RNHPFLTQLFCCFQT | 411 | P24723 |